Back to News
Market Impact: 0.3
AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates
Source: zacks.com
Corporate EarningsCompany FundamentalsAnalyst Estimates
AngioDynamics reported a quarterly loss of $0.04 per share, narrower than the Zacks consensus estimate of a $0.10 loss. The loss also improved from $0.10 per share a year earlier.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
ANGO0.55
More News
- The world needs Ukraine’s grain. Its farmers are running out of reasons to plant
- European bank stocks slide 8% as bond yields spark investor caution
- Why is the Chinese stock market missing the AI rally
- OpenAI's revenue scare, Delta earnings, what investors think of a Starbucks-Chipotle deal and more in Morning Squawk
- Delta Air Lines cuts 2026 forecast on fuel surge, but CEO says demand is still strong
- Why is T-Mobile stock tumbling today?